Viewing Study NCT04236895


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2025-12-29 @ 5:44 PM
Study NCT ID: NCT04236895
Status: COMPLETED
Last Update Posted: 2020-01-22
First Post: 2020-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU LantusĀ® in Type 1 Diabetes Mellitus Patients
Sponsor: Gan and Lee Pharmaceuticals, USA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-07-10
Start Date Type: ACTUAL
Primary Completion Date: 2018-11-28
Primary Completion Date Type: ACTUAL
Completion Date: 2018-11-28
Completion Date Type: ACTUAL
First Submit Date: 2020-01-15
First Submit QC Date: None
Study First Post Date: 2020-01-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-01-17
Last Update Post Date: 2020-01-22
Last Update Post Date Type: ACTUAL